Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain

Dopamine (3-hydroxytyramine) and brain function.

Hornykiewicz, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,389 · see citing works

ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA

McGeer, P. L., & McGeer, E. G. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04437.x · Cited by 476 · see citing works

The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

Lloyd, K. G., Davidson, L., & Hornykiewicz, O. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30363-0 · Cited by 400 · see citing works

A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics

Grima, B., Lamouroux, A., Boni, C., Julien, J., Javoy-Agid, F., & Mallet, J. J. (1987) · Nature · doi:10.1038/326707a0 · Cited by 351 · see citing works

Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography

Nagatsu, T., Oka, K., & Kato, T. (1979) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81411-5 · Cited by 235 · see citing works

Isolation of a novel cDNA clone for human tyrosine hydroxylase: Alternative RNA splicing produces four kinds of mRNA from a single gene

Kaneda, N., Kobayashi, K., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., & Nagatsu, T. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90742-x · Cited by 157 · see citing works

Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain

Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sano, M., Nagatsu, I., Kondo, Y., Inagaki, S., Iizuka, R., Hori, A., et al. (1977) · Clinica Chimica Acta · doi:10.1016/0009-8981(77)90193-0 · Cited by 114 · see citing works

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF

Elsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Brain Research · doi:10.1016/0006-8993(87)90211-3 · Cited by 102 · see citing works

CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.

Riederer, P. F., Rausch, W., Birkmayer, W., Jellinger, K. A., & Seemann, D. (1978) · PubMed · Cited by 57 · see citing works

Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay

Mogi, M., Kojima, K., & Nagatsu, T. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90779-6 · Cited by 51 · see citing works

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content

Mogi, M., Harada, M., Kojima, K., Kiuchi, K., Nagatsu, I., & Nagatsu, T. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90656-2 · Cited by 44 · see citing works

Homospecific activity, an immunologic index of enzyme homogeneity; Changes during the purification of dopamine-β-hydroxylase

Rush, R. A., Kindler, S. H., & Udenfriend, S. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90530-0 · Cited by 40 · see citing works

Purification and immunochemical characterization of human adrenal tyrosine hydroxylase☆

Kojima, K., Mogi, M., Oka, K., & Nagatsu, T. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90117-7 · Cited by 19 · see citing works

Purification and immunochemical properties of tyrosine hydroxylase in human brain

Mogi, M., Kojima, K., Harada, M., & Nagatsu, T. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90017-3 · Cited by 17 · see citing works

Oxidative stress: Free radical production in neural degeneration

Götz, M. E., Künig, G., Riederer, P. F., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 479 · see citing works

Cytokines in Parkinson’s disease

Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6284-2_12 · Cited by 327 · see citing works

Pterin-Dependent Amino Acid Hydroxylases

Kappock, T. J., & Caradonna, J. P. (1996) · Chemical Reviews · doi:10.1021/cr9402034 · Cited by 325 · see citing works

Oxygen free radicals and Parkinson's disease

Adams, J. D., Jr., & Odunze, I. N. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90009-r · Cited by 289 · see citing works

Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease

Elsworth, J. D., & Roth, R. H. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6379 · Cited by 282 · see citing works

Tyrosine Hydroxylase and Parkinson’s Disease

Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263 · see citing works

Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease

Orimo, S., Takahashi, A., Uchihara, T., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00032.x · Cited by 243 · see citing works

Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach

Bézard, E., & Gross, C. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00006-9 · Cited by 213 · see citing works

Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects

Nagatsu, T., & Sawada, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_14 · Cited by 185 · see citing works

Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease

Amino, T., Orimo, S., Itoh, Y., Takahashi, A., Uchihara, T., & Mizusawa, H. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00097.x · Cited by 178 · see citing works

Human tyrosine hydroxylase in Parkinson’s disease and in related disorders

Nagatsu, T., Nakashima, A., Ichinose, H., & Kobayashi, K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1903-3 · Cited by 176 · see citing works

Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson’s disease: possible implications of glial cells

Nagatsu, T., & Sawada, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_7 · Cited by 143 · see citing works

Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects

Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 107 · see citing works

Genes for human catecholamine-synthesizing enzymes

Nagats, T. (1991) · Neuroscience Research · doi:10.1016/0168-0102(91)90001-f · Cited by 103 · see citing works

Brain β2-microglobulin levels are elevated in the striatum in Parkinson's diseaselevels are elevated in the striatum in Parkinson's disease

Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 102 · see citing works

Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression

Riederer, P. F., Strobel, S., Nagatsu, T., Watanabe, H., Chen, X. M., Löschmann, P. A., Sian‐Hülsmann, J., Jost, W. H., Müller, T. H., Dijkstra, J. M., et al. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02893-4 · Cited by 96 · see citing works

Four isoforms of tyrosine hydroxylase are expressed in human brain

Lewis, D. A., Melchitzky, D. S., & Haycock, J. W. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90267-j · Cited by 92 · see citing works

Tyrosine hydroxylase and dopamine transporter expression following 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurodegeneration of the mouse nigrostriatal pathway

Jakowec, M. W., Nixon, K., Hogg, E., McNeill, T., & Petzinger, G. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20114 · Cited by 90 · see citing works

The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes-

Nagatsu, T. (2006) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.82.388 · Cited by 83 · see citing works

Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy

Nagatsu, T. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200061 · Cited by 78 · see citing works

Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin

Nagatsu, T., & Ichinose, H. (1999) · Molecular Neurobiology · doi:10.1007/bf02741379 · Cited by 75 · see citing works

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease

Kästner, A., Hirsch, É. C., Agid, Y., & Javoy-Agid, F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91005-d · Cited by 74 · see citing works

Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis

Kaushik, P., Gorin, F. A., & Vali, S. (2006) · Journal of Computational Neuroscience · doi:10.1007/s10827-006-0004-8 · Cited by 74 · see citing works

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia

Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71 · see citing works

Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model

Park, H. W., Park, C. G., Park, M. J., Lee, S. H., Park, H. R., Lim, J., Paek, S. H., & Choy, Y. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-66493-w · Cited by 67 · see citing works

Immunocytochemical Quantification of Tyrosine Hydroxylase at a Cellular Level in the Mesencephalon of Control Subjects and Patients with Parkinson's and Alzheimer's Disease

Kästner, A., Hirsch, É. C., Herrero, M. T., Javoy-Agid, F., & Agid, Y. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03616.x · Cited by 64 · see citing works

Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines

Nakashima, A., Hayashi, N., Kaneko, Y. S., Mori, K., Sabban, E. L., Nagatsu, T., & Ota, A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0227-8 · Cited by 62 · see citing works

Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment

Fillebeen, C., Mitchell, V. A., Dexter, D. T., Benaı̈ssa, M., Beauvillain, J., Spik, G., & Pierce, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00221-1 · Cited by 56 · see citing works

Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01240-4 · Cited by 54 · see citing works

Cytokines in Parkinson’s Disease

Nagatsu, T., & Mogi, M. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_58 · Cited by 53 · see citing works

From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview

Rausch, W., Wang, F., & Radad, K. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02488-3 · Cited by 52 · see citing works

Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration: A Flow Cytometric Study

Wolf, M. E., Zigmond, M. J., & Kapatos, G. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11786.x · Cited by 51 · see citing works

A possible pathophysiological role of tyrosine hydroxylase in Parkinson’s disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer

Nakashima, A., Ota, A., Kaneko, Y. S., Mori, K., Nagasaki, H., & Nagatsu, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0828-5 · Cited by 47 · see citing works

Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson’s progression: Evidence from clinical studies and neurotoxin models

Johnson, M., Salvatore, M. F., Maiolo, S., & Bobrovskaya, L. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.01.002 · Cited by 47 · see citing works

Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration

Acosta, G., Race, N. S., Herr, S., Fernandez, J., TANG, J. C. Y., Rogers, E. A., & Shi, R. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.004 · Cited by 43 · see citing works

Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy

Zhong, X. H., Haycock, J. W., Shannak, K. S., Robitaille, Y., Fratkin, J., Koeppen, A. H., Hornykiewicz, O., & Kish, S. J. (1995) · Movement Disorders · doi:10.1002/mds.870100104 · Cited by 42 · see citing works

Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle

Sherman, T. G., & Moody, C. A. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00259-h · Cited by 36 · see citing works

3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism

Deutch, A. Y., Rosin, D. L., Goldstein, M., & Roth, R. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90166-0 · Cited by 35 · see citing works

Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity

Nagatsu, T. (1990) · Neurochemical Research · doi:10.1007/bf00969928 · Cited by 34 · see citing works

The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson’s disease

Sian‐Hülsmann, J., & Riederer, P. F. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02192-0 · Cited by 32 · see citing works

Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease

Johnson, M., Lim, Y. P., Senthilkumaran, M., Zhou, X., & Bobrovskaya, L. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.11.002 · Cited by 32 · see citing works

Deprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study

LeWitt, P. A. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05025.x · Cited by 31 · see citing works

Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice

Hood, R. L., Liguore, W. A., Moore, C., Pflibsen, L. R., & Meshul, C. K. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.032 · Cited by 30 · see citing works

Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview

Nagatsu, T. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02673-y · Cited by 29 · see citing works

The human tyrosine hydroxylase gene

Nagatsu, T. (1989) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711412 · Cited by 27 · see citing works

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity

Kolacheva, A. A., Alekperova, L., Pavlova, E., Bannikova, A., & Ugrumov, M. V. (2022) · Brain Sciences · doi:10.3390/brainsci12060779 · Cited by 26 · see citing works

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease

Shehadeh, J., Double, K. L., Murphy, K. E., Bobrovskaya, L., Reyes, S., Dunkley, P. R., Halliday, G. M., & Dickson, P. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104524 · Cited by 25 · see citing works

P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD

Ma, J., Gao, J., Niu, M., Zhang, X., Wang, J., & Xie, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.580068 · Cited by 25 · see citing works

Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction

Tanaka, M., & Vécsei, L. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02812-z · Cited by 23 · see citing works

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes

Wulf, M., Barkovits, K., Schork, K., Eisenacher, M., Riederer, P. F., Gerlach, M., Eggers, B., & Marcus, K. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02530-4 · Cited by 22 · see citing works

TNFα increases tyrosine hydroxylase expression in human monocytes

Gopinath, A., Badov, M., Francis, M. L., Shaw, G., Collins, A., Miller, D. R., Hansen, C. A., Mackie, P. M., Tansey, M. G., Dagra, A., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00201-x · Cited by 22 · see citing works

Changes in retinal dopaminergic cells and dopamine rhythmic metabolism during the development of a glaucoma-like disorder in quails.

Dkhissi‐Benyahya, O., Chanut, E., Versaux‐Botteri, C., Minvielle, F., Trouvin, J., & Nguyen-Legros, J. (1996) · PubMed · Cited by 22 · see citing works

Altered Guanosine and Guanine Concentrations in Rabbit Striatum Following Increased Dopamine Turnover

Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Camp, D. M., DeMaggio, A. J., Milbury, P. E., Matson, W. R., & Rathbone, M. P. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00367-5 · Cited by 21 · see citing works

Retinal alpha-synuclein accumulation correlates with retinal dysfunction and structural thinning in the A53T mouse model of Parkinson’s disease

Tran, K. K. N., Wong, V. H. Y., Hoang, A., Finkelstein, D. I., Bui, B. V., & Nguyen, C. T. O. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1146979 · Cited by 18 · see citing works

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain

Ochi, N., Naoi, M., Mogi, M., Ohya, Y., Mizutani, N., Watanabe, K., Harada, M., & Nagatsu, T. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90348-f · Cited by 18 · see citing works

Brain Neurons Partly Expressing Monoaminergic Phenotype: Distribution, Development, and Functional Significance in Norm and Pathology

Ugrumov, M. V. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_2 · Cited by 18 · see citing works

The Pathophysiological Basis of Parkinson’s Disease

Gerlach, M., & Riederer, P. F. (1993) · Milestones in drug therapy · doi:10.1007/978-3-0348-6348-3_2 · Cited by 18 · see citing works

Central Nervous System Effects of Celastrol, a Potent Antioxidant and Antiinflammatory Agent

ALLISON, A. C., Cacabelos, R., Lombardi, V., Alvarez, X. A., & Vigo, C. (2000) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2000.tb00137.x · Cited by 17 · see citing works

Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid

Loeffler, D. A., LeWitt, P. A., DeMaggio, A. J., Juneau, P. L., Milbury, P. E., & Matson, W. R. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252962 · Cited by 17 · see citing works

GTP cydohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson’s disease

Nagatsu, T., & Ichinose, H. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_21 · Cited by 15 · see citing works

Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson’s disease: historical overview and future prospects

Nagatsu, T. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1604-8 · Cited by 14 · see citing works

Vitamin E and Other Antioxidants in Neurological Function and Disease

Muller, D. P. R. (1994) · Elsevier eBooks · doi:10.1016/b978-0-08-057168-3.50025-4 · Cited by 13 · see citing works

Neurological Disease

Muller, D. P. R. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60999-0 · Cited by 11 · see citing works

Neurochemical and motor changes in mice with combined mutations linked to Parkinson’s disease

Bai, X., Wey, M., Martinez, P. A., Shi, C., Fernández, E., & Strong, R. (2017) · Pathobiology of Aging & Age-related Diseases · doi:10.1080/20010001.2017.1267855 · Cited by 10 · see citing works

Pathobiochemistry of the extrapyramidal system: a “short note” review

Riederer, P. F., Sofic, E., Rausch, W., Hebenstreit, G. F., & Bruinvels, J. (1989) · Key topics in brain research · doi:10.1007/978-3-7091-8994-8_17 · Cited by 9 · see citing works

Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs

Nakashima, A., Kodani, Y., Kaneko, Y. S., Nagasaki, H., & Ota, A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1653-z · Cited by 8 · see citing works

Regulatory mechanism of dopamine biosynthesis in the striatum of transgenic mice carrying human tyrosine hydroxylase gene

Kiuchi, K., Kiuchi, K., Kaneda, N., Sasaoka, T., Hidaka, H., & Nagatsu, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90044-l · Cited by 8 · see citing works

Brain dopaminergic mechanisms in Parkinson's disease evaluated by positron emission tomography

Aquilonius, S., Långström, B., & Tedroff, J. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01783.x · Cited by 7 · see citing works

Tyrosine: Food Supplement or Therapeutic Agent?

TYRRELL, H. A. (1998) · Journal of Nutritional & Environmental Medicine · doi:10.1080/13590849861934 · Cited by 6 · see citing works

Music and Dopamine – Potential in Movement Disorders

Kawahata, K., Kawahata, K., Hasegawa, K., & Kase, R. (2020) · Journal of Brain and Nerves · doi:10.31487/j.jbn.2020.01.02 · Cited by 5 · see citing works

Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?

Sackner‐Bernstein, J. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12526-7 · Cited by 4 · see citing works

Dopamine and Neurodegeneration

Gille, G., & Riederer, P. F. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_18 · Cited by 3 · see citing works

Parkinson's Disease: Mechanisms of Neuronal Death

Kolesnikova, E. E., & Serebrovskaya, T. V. (2003) · Neurophysiology · doi:10.1023/a:1023902507735 · Cited by 3 · see citing works

The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease

Kolacheva, A. A., Pavlova, E., Bannikova, A., Bogdanov, V. V., Troshev, D. V., & Ugrumov, M. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033027 · Cited by 2 · see citing works

Effects of a Novel Psychomotor Stabilizer, IRL790, on Biochemical Measures of Synaptic Markers and Neurotransmission

Bečanović, K., de Donno, M. V., Sousa, V. C., Tedroff, J., & Svenningsson, P. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264754 · Cited by 2 · see citing works

Neopterin and Cytokines in Hereditary Dystonia and Parkinson's Disease

Nagatsu, T., Ichinose, H., Mogi, M., & Togari, A. (1999) · Pteridines · doi:10.1515/pteridines.1999.10.1.5 · Cited by 2 · see citing works

Neuroprotective Effects of MAO-B Inhibition: Clinical Studies in Parkinson’s Disease

LeWitt, P. A. (1993) · Milestones in drug therapy · doi:10.1007/978-3-0348-6348-3_15 · Cited by 2 · see citing works

Molecular Biology of Catecholamine Systems: Multiple Tyrosine Hydroxylases in Different Simian Species, and in Humans in Relation to Parkinson’s Disease

Nagatsu, T., & Ichinose, H. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_94 · Cited by 1 · see citing works

Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA

Javid, H., Rahimian, R., Salimi, M., Haghani-Samani, E., Farhadi, M., & Torkaman‐Boutorabi, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09673-5 · Cited by 1 · see citing works

Pharmacological and clinical-pharmacological aspects of D1 and D2 receptors

HOROWSKI, R., Runge, I., Löschmann, P.-A., Wachtel, H., & Stock, G. (1989) · Key topics in brain research · doi:10.1007/978-3-7091-8994-8_32 · Cited by 1 · see citing works

Tyrosine hydroxylase in relation to Parkinson’s disease: a historical overview and future prospect

Nagatsu, T. (1991) · Key topics in brain research · doi:10.1007/978-3-7091-9146-0_1 · Cited by 1 · see citing works

Insecticide-Mediated Neurochemical and Behavioral Changes as Possible Predisposing Environmental Factors in Idiopathic Parkinson's Disease

Kirby, M. (1998) · VTechWorks (Virginia Tech) · Cited by 1 · see citing works

Oxidative stress

Götz, M. E., Künig, G., Riederer, P. F., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-044482529-2/50039-1 · Cited by 1 · see citing works

Genes of human catecholamine-synthesizing enzymes

Nagatsu, T., Kaneda, N., Kobayashi, K., Ichinose, H., Sasaoka, T., Ishii, A., Sumi‐Ichinose, C., Kiuchi, K., Fujita, K., & Kurosawa, Y. (1991) · Key topics in brain research · doi:10.1007/978-3-7091-9146-0_3 · Cited by 1 · see citing works

Role of noradrenaline in the development of dopamine-induced hyperprolactinemia

Dil’mukhametova, L. K., Pronina, T. S., Ziyazetdinova, G., Кудрин, В. С., & Ugrumov, M. V. (2009) · Neurochemical Journal · doi:10.1134/s1819712409040084

Quantification of Tyrosine Hydroxylase mRNA

Ichinose, H., Ohye, T., Suzuki, T., Inagaki, H., & Nagatsu, T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-142-6:157

Additional file 1 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567958

Additional file 4 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567994

Additional file 13 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567907

Additional file 15 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567949

Additional file 10 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567871

Additional file 6 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15568021

Additional file 7 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15568048

Additional file 5 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15568006

Additional file 2 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567961

Additional file 12 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567889

Additional file 9 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15568078

Additional file 11 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567880

Additional file 8 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15568066

Additional file 3 of Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology

Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15567985

Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity

Nagatsu, T. (1990) · Neurochemical Research · doi:10.1007/bf00969928 · Cited by 34 · see citing works

Tyrosine hydroxylase in relation to Parkinson’s disease: a historical overview and future prospect

Nagatsu, T. (1991) · Key topics in brain research · doi:10.1007/978-3-7091-9146-0_1 · Cited by 1 · see citing works

A possible pathophysiological role of tyrosine hydroxylase in Parkinson’s disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer

Nakashima, A., Ota, A., Kaneko, Y. S., Mori, K., Nagasaki, H., & Nagatsu, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0828-5 · Cited by 47 · see citing works

Tyrosine Hydroxylase Activity in Caudate Nucleus from Parkinson's Disease: Effects of Iron and Phosphorylating Agents

Rausch, W., Hirata, Y., Nagatsu, T., Riederer, P. F., & Jellinger, K. A. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13250.x · Cited by 65 · see citing works

Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism

Kozina, E. A., Khakimova, G. R., Хаиндрава, В. Г., Kucheryanu, V. G., Vorobyeva, N. E., Краснов, А. Н., Georgieva, S., Goff, L. K., & Ugrumov, M. V. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.028 · Cited by 71 · see citing works